Five out of six enrolled dyads completed the sessions. 5 key findings →
Evidence: low
Full summary, score breakdown and related studies → Original source
30,580 Alzheimer's and dementia studies in plain English, each scored out of 100.
Five out of six enrolled dyads completed the sessions. 5 key findings →
Evidence: low
Full summary, score breakdown and related studies → Original source
Hispanic family caregivers of people with dementia experience higher levels of stress compared to non-Hispanic white caregivers. 3 key findings →
Evidence: low
Full summary, score breakdown and related studies → Original source
The COVID-19 pandemic has exacerbated the difficulties faced by caregivers who have to provide continuous '24/7' care to persons with dementia with minimal formal and informal support. 2 key findings →
Evidence: low
Full summary, score breakdown and related studies → Original source
The analysis suggests a complex network of interacting variables. 5 key findings →
Evidence: low
Full summary, score breakdown and related studies → Original source
Twenty-five caregivers participated in one of four intervention groups; 21 caregivers completed the intervention (attended at least five of six group sessions). 4 key findings →
Evidence: low
Full summary, score breakdown and related studies → Original source
Thirty-four studies were included. Psychosocial interventions generating enrichment among dyads mainly involved supporting dyadic engagement in shared activities, carer education or training, or structural change to the environment around PLWD. 5 key findings →
Evidence: low
Full summary, score breakdown and related studies → Original source
In total 148 caregivers participated in the project with 57 of them from Australia (26 and 31 in the qualitative and quantitative strands respectively) and 91 of them from China (23 and 68 in the qualitative and quantitative strands respectively). 5 key findings →
Evidence: moderate
Full summary, score breakdown and related studies → Original source
A total of nine VA family caregivers of PWD participated in this pilot study. 5 key findings →
Evidence: low
Full summary, score breakdown and related studies → Original source
Patients with mild AD had higher total costs, patient medical costs, patient social care costs, and family caregiver informal care costs than did patients with MCI; however, only patient medical costs were significantly different (p = 0.022). 4 key findings →
Evidence: low
Full summary, score breakdown and related studies → Original source
All but one patient showed one or more neuropsychiatric symptoms. 5 key findings →
Evidence: low
Full summary, score breakdown and related studies → Original source
Average caregiver burden on the ZBI was 36.1 (SD = 14.6; range = 12-58). 5 key findings →
Evidence: low
Full summary, score breakdown and related studies → Original source
Most people with dementia live at home and rely on family and friends who provide unpaid care and support. 1 key finding →
Evidence: low
Full summary, score breakdown and related studies → Original source
Almost half of patients of nursing home residents experience one fall per year. 2 key findings →
Evidence: low
Full summary, score breakdown and related studies → Original source
Montessori-based interventions (MBIs) were developed to promote guided participation in meaningful activities by people with dementia patients. 2 key findings →
Evidence: low
Full summary, score breakdown and related studies → Original source
Less than half of administrators found it feasible to close indoor common areas, all community types reported a challenge organizing group activities for safe distancing, and more than half of residents with dementia did not wear a face covering or maintain physical distance from other residents when indicated. 4 key findings →
Evidence: low
Full summary, score breakdown and related studies → Original source
We identified 6 themes regarding financial issues, staffing, appointment logistics, care provision during and after the memory evaluation as well as features of an ideal clinic. 5 key findings →
Evidence: low
Full summary, score breakdown and related studies → Original source
Few studies examine care as a relational process in long-term care, and still fewer describe the participation of residents with dementia. 1 key finding →
Evidence: low
Full summary, score breakdown and related studies → Original source
There were statistically significant improvements in resident well-being (Δ = 0.44, p = 0.029), Positive Engagement Potential (Δ = 0.17, p = 0.002), and Occupational Diversity (Δ = 0.12, p = 0.014) in 2016. 5 key findings →
Evidence: low
Full summary, score breakdown and related studies → Original source
The 9 participants described the importance of understanding the experiences of PLWDs in order to provide high-quality dementia care and to deliver such care with the residents and their preferences as the focus. 5 key findings →
Evidence: low
Full summary, score breakdown and related studies → Original source
We identified the centrality of "being out in the world and negotiating connections," which characterizes residents' experiences with the outside world as a process of "working out" engagement with nature, others, and the community. 5 key findings →
Evidence: low
Full summary, score breakdown and related studies → Original source
Dementia education for healthcare providers has gained growing attention in China. 5 key findings →
Evidence: low
Full summary, score breakdown and related studies → Original source
We conducted a participatory research project to address this important area of care. 5 key findings →
Evidence: low
Full summary, score breakdown and related studies → Original source
About 40 000 individuals depend on assisted living in long-term care facilities in Norway. 5 key findings →
Evidence: low
Full summary, score breakdown and related studies → Original source
Assisted living provides housing and long-term care services to more than 811,000 older adults in the United States daily and is regulated by the states. 3 key findings →
Evidence: low
Full summary, score breakdown and related studies → Original source
In total, 17 papers were included in the final review. 4 key findings →
Evidence: low
Full summary, score breakdown and related studies → Original source
Free full text links and the Full text may need a subscription label come from Unpaywall, Europe PMC and OpenAlex records of free copies, checked 10 Oct 2026. A study with neither is unknown, not paywalled. Show only studies that are free to read
This is alzhub's own score. It is not an official metric, not an impact factor, and no journal, publisher or ranking body endorses it. We built it so that a reader who is not a scientist can tell a landmark trial from a conference abstract without having to already know the difference. Every point comes from one of 20 components, all of them printed on the study itself, so you can disagree with our arithmetic rather than having to trust the total.
Journals are placed in ordered tiers, never given a numeric impact factor — we could not verify current impact factors from a source we control, and an invented one would be worse than none. Tier 1 is the top-tier general journals (NEJM, The Lancet, JAMA, Nature, Science, Nature Medicine); tier 2 is the leading specialty journals; tier 3 is every other peer-reviewed journal. A separate part scores how much the journal's own papers are cited, which tells the tier-3 journals apart.
Two rules we don't bend. First, we never fill in a missing value: if a record does not state a sample size or a design, that component scores zero, and if we simply have no data for a part, such as a citation count, that part is left out and the study is scored on the parts we could check. The study card says which. Second, anything that is not a peer-reviewed article is capped at 16/100 and carries a warning chip — so a conference abstract or a company press release can never outrank a peer-reviewed paper, no matter how good it looks.
We rank a rigorous null result — a good trial showing that something does not work — above an early positive finding. Someone deciding whether to buy a supplement is served by that, and the rigour is already counted by the design and journal components.
The score is computed from the published data alone and is reproducible: the same file always yields the same numbers.
See the whole rubric drawn out → — four charts covering all 30,580 studies: how the scores are spread and where the cap bites, which of the 20 components the library is strong and weak on, which subjects rest on stronger evidence, and what kinds of study each subject is actually built from.
This is a large sample of the Alzheimer's literature, not an exhaustive index of it. It holds 30,580 records, built mostly from automated pulls of Europe PMC (64.7% of the library) and OpenAlex (16.6%), plus smaller pulls from PubMed, Crossref and medRxiv. If a study, a drug, or a finding isn't here, that is not evidence it doesn't exist in the literature — it may simply not have been pulled in yet.
1,037 records (3.4% of the library) are not peer-reviewed — 964 of those are preprints posted before any journal review, and the rest are conference abstracts, regulatory notices and reports. Every study card on this page states its status plainly, and the score above is capped for anything that isn't a peer-reviewed article.
See the full, machine-readable breakdown of this library's coverage →
Newest studies, as a dated timeline → Atom feed Where this research is being discussed: events